Repeated subcutaneous esketamine on treatment|resistant ...

Repeated subcutaneous esketamine on treatment-resistant ...

This groundbreaking study, which addresses SC esketamine treatment for TRD, reported promising response and remission rates, ...

Repeated subcutaneous esketamine on treatment-resistant ...

This pioneering study, which addresses SC esketamine treatment for TRD, reported promising response and remission rates, as well as sustained effects.

Repeated subcutaneous esketamine on treatment-resistant ...

Conclusions. This pioneering study, which addresses SC esketamine treatment for TRD, reported promising response and remission rates, as well as ...

Impact of Repeated Doses of Subcutaneous Esketamine on Acute ...

Background: Esketamine has been approved by the US Food and Drug Administration (FDA) as an adjunctive treatment for use in conjunction with an oral ...

Repeated subcutaneous esketamine for treatment-resistant ...

Repeated subcutaneous esketamine for treatment-resistant depression: Impact of the degree of treatment resistance and anxiety comorbidity. Ana C Lucchese1 ...

Efficacy and safety of a 4-week course of repeated subcutaneous ...

Prior trials suggest that intravenous racemic ketamine is a highly effective for treatment-resistant depression (TRD), but phase 3 trials of ...

Repeated subcutaneous racemic ketamine in treatment-resistant ...

Repeated SC ketamine treatments could be a safe, feasible, and effective alternative to IV ketamine infusions for patients with TRD.

The probability of response after each subcutaneous injection of ...

The administration of multiple esketamine doses has shown efficacy for unipolar and bipolar treatment-resistant depression (TRD). Nevertheless, the probability ...

Impact of Repeated Doses of Subcutaneous Esketamine on Acute ...

Background: Esketamine has been approved by the US Food and Drug Administration (FDA) as an adjunctive treatment for use in conjunction with ...

Effects of subcutaneous esketamine on blood pressure and heart ...

... multiple subcutaneous (s.c.) esketamine ... Effects of subcutaneous esketamine on blood pressure and heart rate in treatment-resistant depression.

Effects of subcutaneous esketamine on blood pressure and heart ...

The BP changes observed with repeated s.c. esketamine injections were mild and well tolerated for doses up to 1 mg/kg, even for patients with clinical ...

Ketamine for the treatment of major depression: a systematic review ...

Intranasal esketamine has received regulatory approvals for the treatment of depression. Recently a large trial of repeated dose racemic ketamine also ...

Impact of the degree of treatment resistance and anxiety comorbidity

The aim of this study was to examine the effect on depressive symptoms of repeated subanesthetic doses of SC esketamine in unipolar and bipolar treatment- ...

Impact of the degree of treatment resistance and anxiety comorbidity

Request PDF | Repeated subcutaneous esketamine for treatment-resistant depression: Impact of the degree of treatment resistance and anxiety comorbidity ...

Synthesizing the Evidence for Ketamine and Esketamine in ...

Ketamine and esketamine represent pharmacologically novel treatment avenues for adults with treatment-resistant depression. In addition to ...

A Clinical Rationale for Assessing the Impact of Childhood Sexual ...

To our knowledge, this is the first protocol investigating CSA as a clinical predictor of response of multiple subcutaneous esketamine ...

Subcutaneous Ketamine in Depression: A Systematic Review

For comparison, the costs estimated for IN esketamine range from U$5,664 to 8,142 for the first month of treatment, while IV racemic ketamine ...

Intravenous Esketamine in Adult Treatment-Resistant Depression

Impact of Repeated Doses of Subcutaneous Esketamine on Acute Dissociative Symptoms in Treatment-Resistant Depression · Medicine. Pharmaceuticals · 2022.

Repeated subcutaneous esketamine on treatment-resistant ... - X-MOL

Additionally, the absence of a control group necessitates cautious interpretation of causality. CONCLUSIONS This groundbreaking study, which addresses SC ...

The probability of response after each subcutaneous injection of ...

Abstract. The administration of multiple esketamine doses has shown efficacy for unipolar and bipolar treatment-resistant depression (TRD). Nevertheless, the ...